168 related articles for article (PubMed ID: 14650835)
1. Allogeneic hematopoetic stem cell transplantation for cytokine refractory renal cell carcinoma.
Drachenberg D; Childs RW
Cancer Treat Res; 2003; 116():213-26. PubMed ID: 14650835
[No Abstract] [Full Text] [Related]
2. Nonmyeloablative transplantation: an allogeneic-based immunotherapy for renal cell carcinoma.
Takahashi Y; Childs RW
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6353S-9S. PubMed ID: 15448030
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem-cell transplantation in renal-cell carcinoma.
Hayes-Lattin BM; Maziarz RT; Beer TM
Curr Oncol Rep; 2001 Sep; 3(5):433-7. PubMed ID: 11489245
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic stem cell transplantation for renal cell carcinoma.
Childs R; Drachenberg D
Curr Opin Urol; 2001 Sep; 11(5):495-502. PubMed ID: 11493771
[TBL] [Abstract][Full Text] [Related]
5. The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy.
Ueno NT; Cheng YC
Bone Marrow Transplant; 2006 Dec; 38(11):711-4. PubMed ID: 17106451
[No Abstract] [Full Text] [Related]
6. Allogeneic stem cell transplantation for renal cell carcinoma.
Bregni M; Herr W; Blaise D;
Expert Rev Anticancer Ther; 2011 Jun; 11(6):901-11. PubMed ID: 21707287
[TBL] [Abstract][Full Text] [Related]
7. Relationship between tumor-infiltrating T lymphocytes and clinical response after reduced-intensity allogeneic hematopoietic stem cell transplantation for advanced renal cell carcinoma: a single center prospective study.
Ishiyama K; Takami A; Suzuki S; Konaka H; Namiki M; Ooi A; Nakao S
Jpn J Clin Oncol; 2009 Dec; 39(12):807-12. PubMed ID: 19770130
[TBL] [Abstract][Full Text] [Related]
8. Nonmyeloablative allogeneic peripheral blood stem-cell transplantation as immunotherapy for malignant diseases.
Childs RW
Cancer J; 2000; 6(3):179-87. PubMed ID: 10882334
[No Abstract] [Full Text] [Related]
9. Immunotherapy for renal cell cancer.
Yang JC; Childs R
J Clin Oncol; 2006 Dec; 24(35):5576-83. PubMed ID: 17158543
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for renal cell carcinoma.
Rosenblatt J; McDermott DF
Hematol Oncol Clin North Am; 2011 Aug; 25(4):793-812. PubMed ID: 21763968
[TBL] [Abstract][Full Text] [Related]
11. Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells.
Harlin H; Artz AS; Mahowald M; Rini BI; Zimmerman T; Vogelzang NJ; Gajewski TF
Bone Marrow Transplant; 2004 Mar; 33(5):491-7. PubMed ID: 14716341
[TBL] [Abstract][Full Text] [Related]
12. Treatment of renal-cell cancer by transplantation of allogeneic stem cells.
Spitzer TR; Sykes M
N Engl J Med; 2001 Jan; 344(2):137-8. PubMed ID: 11188409
[No Abstract] [Full Text] [Related]
13. Immunotherapy for metastatic renal cell carcinoma.
McDermott DF; Rini BI
BJU Int; 2007 May; 99(5 Pt B):1282-8. PubMed ID: 17441925
[No Abstract] [Full Text] [Related]
14. Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancer.
Arya M; Chao D; Patel HR
Nat Clin Pract Oncol; 2004 Nov; 1(1):32-8. PubMed ID: 16264797
[TBL] [Abstract][Full Text] [Related]
15. Long-term graft-versus-tumor effect following reduced intensity hematopoietic stem cell transplantation in a child with metastatic renal cell carcinoma.
Baek HJ; Han DK; Hwang TJ; Bae SH; Choi YD; Kook H
Pediatr Blood Cancer; 2012 Sep; 59(3):583-5. PubMed ID: 22231905
[TBL] [Abstract][Full Text] [Related]
16. Treatment of renal-cell cancer by transplantation of allogeneic stem cells.
Poller DN
N Engl J Med; 2001 Jan; 344(2):137; author reply 138. PubMed ID: 11188411
[No Abstract] [Full Text] [Related]
17. Advances in allogeneic stem cell transplantation: directing graft-versus-leukemia at solid tumors.
Childs R; Srinivasan R
Cancer J; 2002; 8(1):2-11. PubMed ID: 11895199
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
Tykodi SS; Warren EH; Thompson JA; Riddell SR; Childs RW; Otterud BE; Leppert MF; Storb R; Sandmaier BM
Clin Cancer Res; 2004 Dec; 10(23):7799-811. PubMed ID: 15585611
[TBL] [Abstract][Full Text] [Related]
19. Combining allogeneic immunotherapy with an mTOR inhibitor for advanced renal cell carcinoma.
Tykodi SS; Voong LN; Warren EH
Bone Marrow Transplant; 2010 Aug; 45(8):1360-2. PubMed ID: 19966847
[No Abstract] [Full Text] [Related]
20. What's past is prologue: lessons learned and the need for further development of allogeneic hematopoietic stem cell transplantation for renal cell carcinoma.
Ueno NT; Childs RW
Biol Blood Marrow Transplant; 2007 Jan; 13(1):31-3. PubMed ID: 17222750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
